Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8267904 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects
Condition: HIV Infections
Interventions: Biological: HIV p17/p24:Ty-VLP;   Biological: Aluminum hydroxide

Indicates status has not been verified in more than two years